媒体中心

此次合作，双方将在平台建设、技术交流、人员培训及建造生物医药产业生态圈等多方面展开

全球生命科学领域的先行者Cytiva举办“基因药物创新发布会”，重磅推出Sefia细胞治疗生产平台和ELEVECTA稳转细胞系两款新品，并创新性分享脂质纳米颗粒（LNP）如何赋能CRISPR技术，以及高效的细胞培养方案，助力中国基因药物研发与生产者提升安全与效率，加速创新疗法的可及。

Cytiva and Cellular Origins have entered a collaboration designed to revolutionize the manufacture of cell therapies. By combining platforms, CGT manufacturers will be able to scale up production to industrial levels without changing the process.

Cytiva and Cellular Origins have entered a collaboration designed to revolutionize the manufacture of cell therapies. By combining platforms, CGT manufacturers will be able to scale up production to industrial levels without changing the process.

随着可持续发展日益成为生物制药企业成功的关键要素，全球生命科学领域的先行者Cytiva（思拓凡）联合《金融时报》发布《2024全球生物制药可持续发展报告》，揭示行业在可持续发展领域面临的机遇与挑战，为全产业可持续增长提供新思路。

SyVento Biotech has opened its new mRNA manufacturing facility, a FlexFactory delivered by Cytiva. This development represents a significant milestone for SyVento Biotech, enabling the CDMO to accelerate and enhance their service offerings to medicine manufacturers.